Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
GLP-1-based therapies for diabetes, obesity and beyond
2025 Standout
GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease
2024 Standout
Works of Perry Radau being referenced
Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Perry Radau | 279 | 226 | 58 | 85 | 29 | 604 | |
| Oskar Škrinjar | 196 | 133 | 92 | 65 | 18 | 561 | |
| Jennifer L. Cuzzocreo | 235 | 95 | 151 | 74 | 20 | 678 | |
| Constantin Anastasopoulos | 323 | 148 | 17 | 69 | 24 | 678 | |
| Ting Ma | 162 | 111 | 53 | 59 | 65 | 543 | |
| Venkateswaran Rajagopalan | 155 | 271 | 36 | 44 | 34 | 629 | |
| Ann‐Christin Ostwaldt | 193 | 240 | 22 | 41 | 30 | 698 | |
| Guy Poloni | 220 | 235 | 18 | 66 | 23 | 680 | |
| Maurizio Bergamino | 428 | 177 | 17 | 58 | 49 | 739 | |
| Shafik N. Wassef | 153 | 96 | 120 | 30 | 15 | 534 | |
| Boubakeur Belaroussi | 398 | 131 | 112 | 27 | 15 | 738 |
All Works
Loading papers...